Modifié le
Une étude visant à évaluer l’efficacité et la sécurité du dazodalibep, antagoniste du ligand CD40, dans la maladie de Sjögren
Modifié le
A study to assess the efficacy and safety of dazodalibep in Sjögren's disease
A study to assess the efficacy and safety of the CD40 ligand antagonist dazodalibep in Sjögren's disease
Modifié le
Marie Frutoso obtains an ATIP-Avenir grant
Congratulations to Marie Frutoso who obtains an ATIP-Avenir grant which will constitute a major funding for her research programme on the role of NK cells in Sjögren's disease
